Ifu yo Kurwanya Kanseri Ifu ya CAS 114977-28-5 Docetaxel

Ibisobanuro bigufi:

Docetaxel ni igice cya sintetike ya API, kandi igisekuru cya kabiri cyo kurwanya kanseri API kiboneka hamwe na synthesis ya 10-DAB.Ubwinshi bwimitsi ya docetaxel bwikubye inshuro 3 kurenza ubwa paclitaxel, kandi igihe cyo kugumana imitsi ni kirekire, bityo gifite ibikorwa bya antitumor kurusha paclitaxel.Hande Bio numwuga wa docetaxel wabigize umwuga kandi utanga isoko, atanga ifu ya Anti-Kanseri Pharmaceutical Docetaxel Powder CAS 114977-28-5 Docetaxel.Kubindi bisobanuro, nyamuneka twandikire kumurongo.


Ibicuruzwa birambuye

Ibicuruzwa

Amakuru y'ibicuruzwa

Izina:Inyandiko

Numero ya CAS:114977-28-5

Imiti yimiti:C45H57NO14

Ibisobanuro:99%

Ibara:ifu yera

Inkomoko:Igice cya kabiri hamwe na 10-DAB

Ubwoko:APIs

Urufatiro rwo gutera

Hande ibihumbi icumi bya hegitari nyinshi zirimo ibiti byo gutera yew muri Yunnan birashobora guhaza byimazeyo ibikenerwa byibanze.

Impuzandengo ya paclitaxel ni 4 / 10,000, naho 10DAB ni 7/1000, irenze kure iyari isanzwe yatewe.

Ubushobozi bwo gukora

Inzira y'ibicuruzwa:Iminsi 7.

Ubushobozi bwo gutanga umusaruro:hariho ibarura, hariho inzira, kandi umusaruro mwinshi birashoboka.

Hande umukiriya

Isoko rya Hande rikubiyemo Amerika y'Amajyaruguru, Uburayi, Ositaraliya, Ubuhinde, Aziya y'Amajyepfo y'Uburasirazuba n'Ubushinwa.

Muri bo, abakiriya benshi bakoresha ibicuruzwa byacu mugupima kwa kliniki bazemererwa kwamamaza muri 2018-2019.

Serivisi zacu

1.Ibicuruzwa:Tanga ibihingwa byujuje ubuziranenge, bifite isuku nyinshi, ibikoresho bya farumasi, hamwe naba farumasi.

2.Serivisi za tekiniki:Ibicuruzwa byabigenewe bifite ibisobanuro byihariye ukurikije ibyo umukiriya asabwa.

Uruganda

Ba umutanga mwiza wibikoresho fatizo ninganda zifite ubunyangamugayo!

Murakaza neza kundeba mwohereza imeri kurimarketing@handebio.com


  • Mbere:
  • Ibikurikira: